Macrogenics (MGNX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2026 | 03-2026 | 12-2025 | 09-2025 | 06-2025 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -17,259 | -36,774 | -74,620 | -60,465 | -77,287 |
| Depreciation Amortization | 1,213 | 950 | 5,524 | 4,463 | 3,185 |
| Accounts receivable | -23,002 | 2,947 | -9,063 | -64,921 | -8,223 |
| Accounts payable and accrued liabilities | 18 | -776 | -280 | 921 | -388 |
| Other Working Capital | -19,507 | -1,770 | -28,331 | -81,471 | -29,235 |
| Other Operating Activity | -18,022 | -388 | 25,730 | 77,412 | 18,073 |
| Operating Cash Flow | $-76,559 | $-35,811 | $-81,040 | $-124,061 | $-93,875 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 74,433 | 45,662 | -112,194 | -46,437 | -26,492 |
| PPE Investments | -1,150 | -344 | -1,903 | -1,670 | -1,244 |
| Investing Cash Flow | $73,283 | $45,318 | $-114,097 | $-48,107 | $-27,736 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 184 | 11 | 129 | 66 | 66 |
| Other Financing Activity | 59,782 | -218 | 69,385 | 69,391 | 69,391 |
| Financing Cash Flow | $59,966 | $-207 | $69,514 | $69,457 | $69,457 |
| Beginning Cash Position | 57,217 | 57,217 | 182,840 | 182,840 | 182,840 |
| End Cash Position | 113,907 | 66,517 | 57,217 | 80,129 | 130,686 |
| Net Cash Flow | $56,690 | $9,300 | $-125,623 | $-102,711 | $-52,154 |
| Free Cash Flow | |||||
| Operating Cash Flow | -76,559 | -35,811 | -81,040 | -124,061 | -93,875 |
| Capital Expenditure | -1,150 | -344 | -1,914 | -1,670 | -1,244 |
| Free Cash Flow | -77,709 | -36,155 | -82,954 | -125,731 | -95,119 |